Bicycle Therapeutics to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
05 Septembre 2023 - 1:00PM
Business Wire
Bicycle Therapeutics (NASDAQ: BCYC), a biotechnology company
pioneering a new and differentiated class of therapeutics based on
its proprietary bicyclic peptide (Bicycle®) technology, today
announced that management will participate in a fireside chat at
the Morgan Stanley 21st Annual Global Healthcare Conference in New
York on September 12, 2023, at 10:10 a.m. ET.
A live webcast of the fireside chat will be accessible in the
Investors & Media section of Bicycle Therapeutic’s website at
www.bicycletherapeutics.com. An archived replay of the webcast will
be available following the event.
About Bicycle Therapeutics
Bicycle Therapeutics is a clinical-stage biopharmaceutical
company developing a novel class of medicines, referred to as
Bicycles, for diseases that are underserved by existing
therapeutics. Bicycles are fully synthetic short peptides
constrained with small molecule scaffolds to form two loops that
stabilize their structural geometry. This constraint facilitates
target binding with high affinity and selectivity, making Bicycles
attractive candidates for drug development. Bicycle is evaluating
BT5528, a second-generation Bicycle Toxin Conjugate (BTC™)
targeting EphA2; BT8009, a second-generation BTC targeting
Nectin-4, a well-validated tumor antigen; and BT7480, a Bicycle
TICA™ targeting Nectin-4 and agonizing CD137, in company-sponsored
Phase 1/2 trials. In addition, BT1718, a BTC that targets MT1-MMP,
is being investigated in an ongoing Phase 1/2a clinical trial
sponsored by the Cancer Research UK Centre for Drug Development.
Bicycle is headquartered in Cambridge, UK, with many key functions
and members of its leadership team located in Cambridge, MA. For
more information, visit bicycletherapeutics.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230905198369/en/
Investors: Stephanie Yao SVP, Investor Relations &
Corporate Communications ir@bicycletx.com 617-945-8155
Media: Argot Partners Sarah Sutton
bicycle@argotpartners.com 212-600-1902
Bicycle Therapeutics (NASDAQ:BCYC)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Bicycle Therapeutics (NASDAQ:BCYC)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024